PNC Financial Services Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.6K | Buy |
|
|||||
|
2025
Q1 | $56.3K | Sell |
|
|||||
|
2024
Q4 | $90.9K | Sell |
|
|||||
|
2024
Q3 | $245K | Sell |
|
|||||
|
2024
Q2 | $231K | Buy |
|
|||||
|
2024
Q1 | $112K | Sell |
|
|||||
|
2023
Q4 | $107K | Sell |
|
|||||
|
2023
Q3 | $102K | Sell |
|
|||||
|
2023
Q2 | $154K | Sell |
|
|||||
|
2023
Q1 | $160K | Buy |
|
|||||
|
2022
Q4 | $84.1K | Buy |
|
|||||
|
2022
Q3 | $105K | Sell |
|
|||||
|
2022
Q2 | $102K | Buy |
|
|||||
|
2022
Q1 | $138K | Sell |
|
|||||
|
2021
Q4 | $169K | Buy |
|
|||||
|
2021
Q3 | $159K | Sell |
|
|||||
|
2021
Q2 | $164K | Buy |
|
|||||
|
2021
Q1 | $162K | Buy |
|
|||||
|
2020
Q4 | $91K | Buy |
|
|||||
|
2020
Q3 | $61K | Buy |
|
|||||
|
2020
Q2 | $28K | Sell |
|
|||||
|
2020
Q1 | $75K | Buy |
|
|||||
|
2019
Q4 | $126K | Buy |
|
|||||
|
2019
Q3 | $124K | Buy |
|
|||||
|
2019
Q2 | $89K | Sell |
|
|||||
|
2019
Q1 | $131K | Buy |
|
|||||
|
2018
Q4 | $112K | Sell |
|
|||||
|
2018
Q3 | $201K | Buy |
|
|||||
|
2018
Q2 | $136K | Buy |
|
|||||
|
2018
Q1 | $100K | Sell |
|
|||||
|
2017
Q4 | $123K | Buy |
|
|||||
|
2017
Q3 | $117K | Buy |
|
|||||
|
2017
Q2 | $56K | Sell |
|
|||||
|
2017
Q1 | $354K | Buy |
|
|||||
|
2016
Q4 | $24K | Sell |
|
|||||
|
2016
Q3 | $32K | Sell |
|
|||||
|
2016
Q2 | $362K | Sell |
|
|||||
|
2016
Q1 | $1.01M | Buy |
|
|||||
|
2015
Q4 | $630K | Buy |
|
|||||
|
2015
Q3 | $513K | Sell |
|
|||||
|
2015
Q2 | $797K | Buy |
|
|||||
|
2015
Q1 | $818K | Buy |
|
|||||
|
2014
Q4 | $706K | Buy |
|
|||||
|
2014
Q3 | $688K | Buy |
|
|||||
|
2014
Q2 | $380K | Buy |
|
|||||
|
2014
Q1 | $235K | Buy |
|
|||||
|
2013
Q4 | $37K | Sell |
|
|||||
|
2013
Q3 | $105K | Sell |
|
|||||
|
2013
Q2 | $417K | Buy |
|